Home » Topics » Regulatory » Patents

Patents
RSS

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

May 3, 2022

Storm Therapeutics identifies new METTL3 inhibitors

May 3, 2022

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

May 3, 2022

New mucolipin-1 activators identified at Lysoway Therapeutics

May 2, 2022

Curome Biosciences presents new quinone derivatives

May 2, 2022

Vertex Pharmaceuticals discovers CFTR modulators

May 2, 2022

New KCNA3 channel blockers identified at DE Shaw Research

May 2, 2022

Bristol Myers Squibb describes new FPR1/2 agonists

May 2, 2022

BioWorld MedTech Patent Highlights: Week 16

From Current Patent Gazette

April 29, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...